Clinical Trials Logo

Filter by:
NCT ID: NCT06317584 Not yet recruiting - Diabetes Clinical Trials

Empowerment-based Complementary and Alternative Medicine (ECAM)

CAM
Start date: April 1, 2024
Phase: N/A
Study type: Interventional

This phase study will use a randomized trial method to evaluate the performance of the ECAM educational app in the promotion of CAM health literacy and communication among patients with diabetes.

NCT ID: NCT06315374 Not yet recruiting - Clinical trials for Chronic Pulmonary Disease

3D-Printed Aerosolized Medication Delivery Assist Device in Patients With Chronic Respiratory Diseases

Start date: March 30, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the auxiliary benefits of three-dimensional printed activating assistive devices for soft-mist inhaler on patients' utilization habit.

NCT ID: NCT06297720 Not yet recruiting - Anesthesia Clinical Trials

Early Oral Hydration After Thoracoscopic Surgery

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about the safety and feasibility of early oral hydration in patients receiving video-assisted thoracoscopic surgery after general anesthesia. The main questions aims to answer: - the safety and feasibility of oral hydration supplementation in the recovery room following general anesthesia. - the degree of improvement in sore throat and dry mouth after oral hydration. - the side effects and risks of oral hydration supplementation, such as the incidence of postoperative nausea and vomiting. - the impact of oral hydration supplementation in the recovery room following general anesthesia on hemodynamics. - patient satisfaction with oral hydration supplementation in the recovery room following general anesthesia. Participants will receive a series of oral hydration from swab moistening, and ice cube hydration to water hydration in the recovery room. Researchers will compare with the standard, no-hydration group to see if it is safe and feasible to hydrate patients in the recovery room.

NCT ID: NCT06290258 Not yet recruiting - Healthy Clinical Trials

Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.

Start date: March 1, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This study aims to evaluate the efficacy of fecal microbiota transplantation on the gastrointestinal symptoms, autistic symptoms and emotional behavior symptoms of patients with autism spectrum disorder, and investigate the relations between the brain-gut axis, cytokines and autism spectrum disorder. Fecal microbiota transplantation have the potentials to improve intestinal microbiota composition, regulate immunity, and then improve gastrointestinal symptoms, autistic symptoms, emotional behavior symptoms and sleep of children with autism spectrum disorder. Early intervention at school-age may even benefit development, improve cognition and prognosis.

NCT ID: NCT06290219 Not yet recruiting - Effect of Drug Clinical Trials

The Effect of Platelet-rich Plasma Nasal Injection in the Treatment of Traumatic Olfactory Dysfunction

PRP
Start date: March 20, 2024
Phase: Phase 3
Study type: Interventional

The purpose of this study is to explore the efficacy of injecting high-concentration platelet plasma combined with hyaluronic acid into the nasal olfactory mucosa in the treatment of traumatic anosmia.

NCT ID: NCT06277440 Not yet recruiting - Clinical trials for Developmental Delays

Cognitive Training for Attention Deficit Hyperactivity Disorder and Developmental Delays

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

To explore whether children with Attention Deficit Hyperactivity Disorder and developmental delays who receive cognitive training and conventional rehabilitation can improve executive function more than traditional rehabilitation alone. A magnetoencephalographic examination will be arranged to explore how brain network activation works. Research method: 20 preschool children with Attention Deficit Hyperactivity Disorder and developmental delays under rehabilitation therapy will be collected. They will be randomly assigned to the experimental group (receiving rehabilitation therapy and three times per week for 15 minutes, a total of 12 weeks of interactive cognitive training) and the control group (receiving rehabilitation therapy only). Therapeutic effects will be evaluated.

NCT ID: NCT06277037 Not yet recruiting - Long Term Follow-up Clinical Trials

Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)

Start date: July 15, 2024
Phase:
Study type: Observational

This is a long term follow-up study for chronic hepatitis B (CHB) subjects who have received imdusiran treatment in a prior clinical trial, stopped NA therapy during that trial, and remain off therapy. Subjects may enroll after completing the end of study visit (baseline visit within 12 weeks ± 1 week from the end of study [EOS] visit) from their imdusiran clinical trial (the "parent study"). No interventions will be performed in this study other than blood sample collections, review of current medications, and reporting of any adverse events related to study procedures or NA therapy if restarted. Study participation will be for approximately 2 years (to complete a total of at least 3 years of follow-up while off NA therapy, inclusive of parent study participation).

NCT ID: NCT06264830 Not yet recruiting - Cataract Clinical Trials

3D Visualization System in Highly Myopic Cataract Operation

3D-HiMCO
Start date: June 2024
Phase: N/A
Study type: Interventional

This study aims to investigate the impact of depth of field differences between the use of the 3D imaging system (NGENUITY® 3D Visualization System, Alcon, TX, USA) and conventional optical microscope in cataract surgery for highly myopic patients on intraoperative parameters and outcomes.

NCT ID: NCT06263127 Not yet recruiting - Preterm Infants Clinical Trials

Sensory Motor Interventions on Preterm Infants

Start date: February 20, 2024
Phase: N/A
Study type: Interventional

Preterm infants experiencing bottle feeding difficulties will be included in this study. Two distinct interventions, oral stimulation (OS) and infant massage (IM), will be administered in this study. The objective of this clinical trial is to compare the effectiveness of these two approaches, either individually or in combination, in improving the feeding performance and development of participants.

NCT ID: NCT06258577 Not yet recruiting - Gaucher Disease Clinical Trials

Screening for Gaucher Disease and Acid Sphingomyelinase Deficiency

Start date: May 1, 2024
Phase:
Study type: Observational

High-risk screening for Gaucher disease and Acid Sphingomyelinase Deficiency in patients with splenomegaly and/or thrombocytopenia in Taiwan